Video: Interview With Christopher Viehbacher Of Gurnet Point Capital
Executive Summary
Since his departure from Sanofi, Viehbacher has taken on a significant role in venture capital; at the recent BioPharm America conference, he spoke about his company's business model and goals, as well as the trend of pharma execs moving to smaller companies.